Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
Yang Yu(Sichuan University), Q. Richard Lu(Cincinnati Children's Hospital Medical Center), Jonah R. Chan(University of California, San Francisco), Haibo Wang(Foundation Center), BongWoo Kim(Konkuk University), Lai Man Natalie Wu(Cincinnati Children's Hospital Medical Center), Xuelian He(Wuhan Children's Hospital), Lei Liu(Shanghai Jiao Tong University), Ying Chen(Ludwig-Maximilians-Universität München), Wei Liu(Shanghai University of Traditional Chinese Medicine), Jiang Wu(Guangdong Ocean University), Meng Mao(Guiyang Medical University), Chuntao Zhao(Cincinnati Children's Hospital Medical Center)
Cited by 384
Related Papers
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375
Birth Weight Reference Percentiles for Chinese
|PLoS ONE|2014|369